Skip to main content

Table 1 Baseline characteristics between CN and DQ groups

From: RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial

   

Mean ± SD (Range)

CN (n = 58)

DQ (n = 57)

p-value

Age (years)

47.21 ± 15.91 (24 ~  81)

43.86 ± 16.74(22 ~  79)

0.2594

Gender (M/F)a

6/52

7/50

0.7431

Corneoconjunctival staining (NEI scale)

10.78 ± 5.02 (4.00 ~  27.00)

10.25 ± 4.89 (4.00 ~  23.00)

0.5220

 Corneal staining

5.47 ± 1.70 (4.00~10.00)

5.68 ± 1.84 (4.00 ~  10.00)

0.5968

 Conjunctival staining

5.31 ± 4.18 (0.00 ~  18.00)

4.56 ± 3.71(0.00 ~  15.00)

0.3089

TBUT (sec)

3.87 ± 1.32 (1.05 ~  8.67)

4.29 ± 1.85 (0.50 ~  8.42)

0.3459

Schirmer test (mm)

8.67 ± 6.30 (2.00 ~  35.00)

7.96 ± 5.55 (1.00 ~  30.00)

0.3955

OSDI (0–100)

43.36 ± 20.61 (8.00 ~  94.00)

42.46 ± 18.90 (2.00 ~  98.00)

0.8065

  1. Comparison between CN and DQ groups by Wilcoxon rank sum test
  2. CN 0.05% cyclosporin nanoemusion (0.5 mg/mL), DQ 3% diquafosol sodium (30 mg/mL), SD standard deviation, TBUT tear break up time, OSDI ocular surface disease index
  3. aχ2 test